01 SUN PHARMACEUTICAL INDUSTRIES LTD. (1)
02 Mac-Chem Products (India) Pvt.Ltd. (1)
03 Acebright (India) Pharma Private Limited (1)
04 Cdymax (India) Pharma Private Limited (1)
05 Cipla Limited (3)
06 Cipla Limited. (1)
07 FIS FABBRICA ITALIANA SINTETICI SPA@FIS FABBRICA ITALIANA SINTETICI SPA (1)
08 Hetero Labs Limited (Unit-I) (1)
09 Intas Pharmaceuticals Limited (1)
10 Jeil Pharmaceutical Co., Ltd. (1)
11 Kyeong Pharmaceutical Co., Ltd. (1)
12 Kyungbo Pharmaceutical Co., Ltd.@Jari Pharmaceutical Co., Ltd. (1)
13 Leeyeon Pharmaceutical Co., Ltd. (1)
14 Natco Pharma Limited (4)
15 Nosch Labs Pvt. Ltd (3)
16 PLIVA Croatia Ltd. (1)
17 Qilu Tianhe Pharmaceutical (1)
18 ST Pharm Co., Ltd._x000D_ (1)
19 Samhwa Biopharm Co., Ltd. (1)
20 Shilpa Medicare Limited (1)
21 Shilpa Pharma Lifesciences Limited (1)
22 Shinpoong Pharmaceutical Co., Ltd. (1)
23 Sterling Pharma Ringaskiddy Limited@[sieving process manufactory]Novartis Pharma Stein AG (1)
24 Suven Life Sciences Ltd (1)
01 Alvogen Korea Co., Ltd. (1)
02 Boryeong Co., Ltd. (1)
03 Chong Kun Dang Co., Ltd. (1)
04 Classia Co., Ltd. (1)
05 Dasan Pharmaceutical Co., Ltd. (1)
06 HK Innoen Co., Ltd. (1)
07 Hyundai Bioland Co., Ltd. (1)
08 Ildong Pharmaceutical Co., Ltd. (1)
09 Jeil Pharmaceutical Co., Ltd. (1)
10 Kookjeon Pharmaceutical Co., Ltd. (1)
11 Korea United Pharmaceutical Co., Ltd. (1)
12 Kyungbo Pharmaceutical Co., Ltd. (2)
13 Leeyeon Pharmaceutical Co., Ltd. (1)
14 Masung LS Co., Ltd. (1)
15 Novartis Korea Co., Ltd. (2)
16 ST Pharm Co., Ltd. (1)
17 Samhwa Biopharm Co., Ltd. (1)
18 Samo Pharmaceutical Co., Ltd. (2)
19 Sampoong Pharmachem Co., Ltd. (1)
20 Seongui Bio Co., Ltd. (1)
21 Shinpoong Pharmaceutical Co., Ltd. (1)
22 Sungwoo Chemical Co., Ltd. (2)
23 Toru Co., Ltd. (1)
24 UN Generic Co., Ltd. (1)
25 UNUST Co., Ltd. (1)
26 Wonpoong Pharmaceutical Co., Ltd. (1)
27 Yuhan Corporation (1)
01 Imatinib Mesylate (27)
02 Imatinib mesylate (4)
01 China (1)
02 Croatia (1)
03 India (20)
04 Italy (1)
05 South Korea (6)
06 Switzerland (1)
07 Blank (1)
82
PharmaCompass offers a list of Imatinib Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Imatinib Mesylate manufacturer or Imatinib Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Imatinib Mesylate manufacturer or Imatinib Mesylate supplier.
PharmaCompass also assists you with knowing the Imatinib Mesylate API Price utilized in the formulation of products. Imatinib Mesylate API Price is not always fixed or binding as the Imatinib Mesylate Price is obtained through a variety of data sources. The Imatinib Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Imatinib Mesilate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imatinib Mesilate, including repackagers and relabelers. The FDA regulates Imatinib Mesilate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imatinib Mesilate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Imatinib Mesilate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Imatinib Mesilate supplier is an individual or a company that provides Imatinib Mesilate active pharmaceutical ingredient (API) or Imatinib Mesilate finished formulations upon request. The Imatinib Mesilate suppliers may include Imatinib Mesilate API manufacturers, exporters, distributors and traders.
click here to find a list of Imatinib Mesilate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Imatinib Mesilate Drug Master File in Korea (Imatinib Mesilate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Imatinib Mesilate. The MFDS reviews the Imatinib Mesilate KDMF as part of the drug registration process and uses the information provided in the Imatinib Mesilate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Imatinib Mesilate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Imatinib Mesilate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Imatinib Mesilate suppliers with KDMF on PharmaCompass.
We have 20 companies offering Imatinib Mesilate
Get in contact with the supplier of your choice: